Pharmagreen Biotech Inc. (PHBI)
OTCMKTS · Delayed Price · Currency is USD
0.0019
+0.0001 (5.56%)
Oct 27, 2025, 3:50 PM EDT
Pharmagreen Biotech Market Cap
Pharmagreen Biotech has a market cap or net worth of $1.26 million as of October 27, 2025. Its market cap has decreased by -54.76% in one year.
Market Cap
1.26M
Enterprise Value
1.57M
Revenue
3.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 5, 2018, Pharmagreen Biotech's market cap has decreased from 57.68M to 1.26M, a decrease of -97.81%. That is a compound annual growth rate of -40.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 1.26M | 26.67% |
| Dec 31, 2024 | 995.47K | 150.00% |
| Dec 29, 2023 | 398.19K | -71.75% |
| Dec 30, 2022 | 1.41M | -81.11% |
| Dec 31, 2021 | 7.46M | 186.64% |
| Dec 31, 2020 | 2.60M | -95.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 668.66M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 337.25M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |